For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...
The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not ...
Research shows including students with and without disabilities in the same classroom can benefit everyone. Two students with Down syndrome show what can be gained when that happens.
Comedian Whitney Cummings told her podcast listeners this week that the left has become so hypocritical and censorious that ...
The doctor cautioned us that the treatment contained risks, including that it might not remedy the situation. He told us that we had to decide if we wanted to proceed with it or not.